Upcoming events

Metrion Biosciences Upcoming Events

Upcoming events calendar

Metrion Biosciences holds and participates in numerous events each year for professional development, knowledge sharing, self-improvement and networking opportunities. Below you will find a list of all our upcoming events, please follow the links to find out more information about any of them.

Please schedule a meeting with us to discuss any questions or any specific ion channel and assay requirements. We look forward to meeting you shortly.

Sophion Ion Channel Modulation Symposium 2022 – USA

November 5th @ 9am EDT-
November 6th @ 5pm EDT

Metrion Biosciences is attending the Sophion Ion Channel Modulation Symposium , taking place on 5th and 6th November 2022 at New York University, USA.

Metrion’s VP, US Commercial Operations, Dr Rory Curtis will be attending the meeting and if you would to meet with him, please email info@metrionbiosciences.com.

The Ion Channel Modulation Symposium gathers a broad range of people from academia, CROs and pharmaceutical companies to discuss the science of ion channel modulation. The symposium provides more than 20 speakers with an audience of 130 and has been fully attended in both 2016, 2017, 2018 and 2019.

Speakers will address a spectrum of ion channel topics, such as new therapeutic targets, advances in the understanding of ion channel protein structures, advances in techniques for the study of ion channels and ‘traditional’ ion channel targets such as pain, inflammation, cardiovascular and neurological. The meeting aims to cover a broad range of ion channels and present issues that are important in their modulation for the purpose of drug discovery and look at innovative technologies and approaches to this research.

Find out more...

XIV Spanish Drug Discovery Network Meeting 2022

November 24th @ 9am EDT –
November 25th @ 5pm EDT

Metrion Biosciences is attending the XIV Spanish Drug Discovery Network Meeting, taking place on 24th and 25th November 2022 at Parque Tecnológico de la Salud (PTS) / Universidad de Granada, in Granada, Spain.

Metrion’s Head of European Business Development, Dr Benedetta Montagnini will be attending the meeting and if you would to meet with her, please email info@metrionbiosciences.com.

The international conference is an ideal forum for the early drug discovery community, both from Academia and Industry.  Every year there are a limited number of topics with the idea to facilitate an “in-depth” discussion among professionals with very different backgrounds, but all focused on advancing the frontline of drug discovery and translational medicine research.

This year, the programme will focus on four scientific areas that are continuously evolving and increasingly having an impact on drug discovery:

  • Targeted Protein Degradation
  • Nucleic Acids as Therapeutic Agents
  • Antimicrobial Resistance and New Antibiotics
  • Biologics in Drug Discovery and Development.

Included is a Round Table Discussion about “How to potentiate Drug Discovery in Spain”.

Find out more...

Metrion Webinar – Dr Manoj Patel

November 29th @ 4pm GMT

November 29th @5pm GMT

Metrion Biosciences “Ion Channels in Drug Discovery” webinar series will take place again this November. Manoj K. Patel, Ph.D, Associate Professor at the University of Virginia will speak about “Gain-of-function mutations in Nav1.6 and epileptic seizures“.

A summary of the talk is given below:

Many de novo missense mutations of SCN8A, the gene that encodes for Nav1.6, have been identified and patients have seizure onset between birth and 12 months of age. Patients with these mutations have seizures that are difficult to control. As such, they have an increased chance of dying unexpectedly from a seizure (SUDEP). My laboratory has begun to evaluate a number of these patient mutations. We have shown that Nav1.6 mutations that are associated with seizure onset are typically gain-of-function (GOF) mutations, while loss-of-function (LOF) mutations are typically associated with intellectual disability (ID) and sometimes absence seizures. Using two mice mouse models of SCN8A epilepsy we have began to evaluate the effects of GOF mutations on both excitatory and inhibitory neurons to better understand how alterations in the biophysical properties of Nav1.6, as a result of a mutation, can facilitate seizure onset.

Find out more...


December 7th @ 9am GMT

December 7th @5pm GMT

Metrion Biosciences’ Chief Commercial Officer, Nick Foster is attending the GENESIS Conference, taking place on 7th December 2022 at the Royal Society of Medicine on Wimpole Street, London.

If you would to arrange a meeting with Nick, please email info@metrionbiosciences.com.

The annual Genesis conference has been a pillar of the Life Science sector for over two decades. Bringing together key opinion leaders, investors and innovators from across the sector to share insight, debate key trends and generate deals.

The headline theme of the year is “Maximising Returns from Life Science Innovation” the event will feature: 

  • A keynote programme of presentations and panels provoking debate around the programme theme
  • An exhibition area for sponsors to engage with their key client base
  • Online 1-2-1 partnering meetings and networking
  • Online Innovation Workshops throughout the week
  • Satellite event options in the Genesis Fringe
  • Ample time for in-person networking

Find out more...

Biophysical Society (BPS) Annual Meeting

February 18th @ 9am PST February 22nd @ 5pm PST

Metrion Biosciences is sponsoring and attending the 2023 Biophysical Society Annual Meeting taking place at the San Diego Convention Center, 111 W Harbor Dr, San Diego, CA 92101, USA from 18th to 22nd February 2023.

Metrion will have two delegates attending the meeting and if you would to meet with them please email info@metrionbiosciences.com.

Metrion will also be sponsoring the ‘Drug Discovery for Ion Channels’ Satellite meeting taking place on Friday 17th February 2023.

The Biophysical Society annual meetings are the largest annual gathering of biophysicists around the world. The meetings include symposia, workshops, 15 subgroup programs, over 500 platform speakers selected from submitted abstracts, the Biophysical Society Lecture, more than 4,000 packed poster presentations, as well as educational exhibits, exhibitor presentations, and career development sessions.

Find out more...

Metrion Biosciences is sponsoring and attending the 7th RSC-BMCS / SCI Symposium on Ion Channels as Therapeutic Targets, taking place on 27th and 28th March 2023 at the Wellcome Genome Campus, Cambridge.

Metrion will have a delegate attending the meeting and if you would to meet with them please email info@metrionbiosciences.com.

Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been discovered for diseases such as hypertension, epilepsy and neuropathic pain. 

This symposium, the 7th in an ongoing series, will showcase the most recent advances to aid the design of new ion channel therapeutics and promote interaction between scientists with a shared interest in the field of ion channel drug discovery.

Find out more...

Metrion Biosciences is attending the Sophion meeting entitled “Ion Channels in Cancer Biology from Signaling to Therapy”, taking place from 17th – 19th April 2023, in Capua, Italy.

Metrion’s Head of European Business Development, Dr Benedetta Montagnini will be attending the meeting and if you would to meet with her, please email info@metrionbiosciences.com.

This international symposium will be an inaugural 3-day scientific event providing one kind of platform for critical analysis and to share latest cutting-edge research findings, most recent movements and latest upgrades inside the new field of “Ion Channels and Cancer”.

Traditionally, changes of ionic gradients are known to control a variety of rapid biological processes including action potentials and secretion. However, mounting evidence suggests a critical role of ion channels in cell proliferation and/or survival with implication in physiology as well as in diseases such as cancer. Nevertheless, the role of specific classes of ion channels in controlling these events and the possibility of targeting ion channels as anticancer therapy are still understudied.

The symposium will gather selected academics and industry-based scientists in the field of ion channels in cancer.

Find out more...

Wave Background thinner 01 1
Metrion Ion Channel Screening Icon 01

Schedule a meeting with us at an event

Do you have a passion for ion channel drug discovery?

If you would like to arrange a meeting with Metrion’s booth representatives at any event, please email us at info@metrionbiosciences.com or contact your Metrion contact directly. We look forward to seeing you at our upcoming events.